https://www.selleckchem.com/pr....oducts/nedometinib.h
PDAS, pain catastrophizing, and pain self-efficacy were significantly improved immediately after the program compared with baseline, and these effects were maintained at 3-month follow-up. The effect size (d) for the PDAS score was a medium size (0.54) from baseline to 3-month follow-up. Those who showed improvements in TUG immediately after the program tended to report improved psychometric measures at 3-month follow-up. These results suggest that the Japanese multidisciplinary program has a similar effect on pain disability as tha
Like
Comment
Share
